S29 incident osteophytes at 30 months, respectively, using Poisson regression with GEE in knee-based analyses. We performed additional analyses on a subregion-basis. Given the systemic effects of vitamin K, we also performed person-based analyses examining the relation of vitamin K deficiency with risk for having incident OA in 1 or 2 knees. All analyses were adjusted for age, sex, BMI, BMD and 25(OH)-vitamin D. Results: Among 1180 participants (62% women, mean age 62±7.9 years, mean BMI 30.1±5.1 kg/m 2 , median vitamin K 1.2 nM), 21% developed incident knee OA over 30 month follow-up and 9.2% were vitamin K deficient at baseline. In the knee-based analyses, compared with those who were not vitamin K deficient, those who were deficient had 1.43 times higher risk of incident radiographic OA (95% CI 0.98-2.09), and 2.82 times higher risk of incident cartilage abnormality (95% CI 1.26-6.30). Vitamin K deficiency was not statistically significantly associated with incident osteophytes in the knee-based analyses (RR 1.77, 95% CI 0.41-7.55), although this sample was small as most knees had some osteophytes at baseline and were therefore excluded. The risk of incident osteophytes on a subregion basis was similar to the knee-based analyses (RR 1.61,). In the person-based analyses, those who were vitamin K deficient were more likely to develop incident OA in 2 knees versus 0 knees (RR 2.07, 95% CI 1.28-3.36), 2 knees versus 1 knee (RR 2.76, 95% CI 0.99-7.69) and 1 knee versus 0 knees (RR 1.23, 95% CI 1.01-1.50). Conclusions: In this first longitudinal study of vitamin K in OA, we found that vitamin K deficiency was associated with an increased risk of incident knee OA, extending prior cross-sectional findings, as well as with incident cartilage abnormalities. We could not detect an association with incident osteophytes but most knees had osteophytes at baseline, limiting sample size for this analysis. Further study of vitamin K is warranted given its potential to be a simple and effective preventive agent. 
Purpose:
The Osteoarthritis Initiative provides an excellent source of public use data for the study of prognostic factors that may influence pain and functional status of patients with knee osteoarthritis. An extensive literature has examined various prognostic factors but little research has been done to determine if mental health constructs impact future knee pain or function. The goals of this study were to determine whether baseline depression (measured with the CESD), knee related confidence (measured on a Likert scale) and general psychological distress (measured with the SF-12) influenced the change in pain and functional status outcomes during two years of follow up. Methods: To define the sampling frame we included only persons who reported baseline pain of 1 or greater on a 0 to 10 scale in at least one knee and had no knee or hip surgery during the two-year follow-up (n=3407). The four outcome variables of interest included performance-based measures of repeated chair standing and the 20 meter walk test, and self report measures of pain and disability (WOMAC) where the worst score of the two knees was used as a person-level measurement. Linear mixed effects models were used to assess the association of each mental health variable with the change of each outcome measure over time. Examination of the descriptive data for the entire sample indicated that little change occurred in the outcome measures. As importantly, change was highly dependent on baseline outcome score. For example, persons scoring in the lowest quartile (least pain) on WOMAC Pain at baseline increased their mean score by 0.2 WOMAC points at 1 year while persons in the highest quartile (worst pain) had reductions in their mean 1 year scores of 6.6 WOMAC points. Because change was highly dependent on baseline outcome, we adjusted for the baseline score for all analyses. All variables prognostic of pain or function identified in previously published large sample cohort studies were considered, and covariates significantly associated with the change in outcome at significance level 0.10 were included in the multivariate analyses to determine the independent role of each of the mental health variables on outcome. Results: Depression was significantly predictive of the change in WOMAC Pain and Disability outcomes, 20 meter walk time and repeated chair stand time. However, given the very small changes overall in the outcomes, the magnitude of change predicted for each year was very small. For example, for WOMAC pain, each point increase in depression at baseline resulted in a 0.02 point increase in WOMAC Pain scores each year. This finding was highly significant (p=.0008) and very robust (Estimate = 0.02, Standard error = 0.006). Knee confidence was not predictive of change for any outcome. General psychological distress as measured with the SF-12 Mental Health score was predictive of change in 20 meter walk times and WOMAC Pain.
Conclusions:
The most consistent psychological predictor of the change in WOMAC and performance outcomes during the two-year follow up was depression. Although depression in particular appears to be a statistically robust predictor of outcome, given that change is very small and highly dependent on baseline status, our results indicate that a considerable degree of depression would be required to have a meaningful effect on future function. Purpose: Biological markers have the potential to aid in the identification of people in the earliest stage of osteoarthritis (OA), prior to any evidence of radiographic disease, when interventions would be most efficacious. We have recently shown that bone scintigraphy is a sensitive indicator of symptomatic knee OA and may be a useful marker of early OA events related to bone turnover. Urinary ALPHA CTX, a marker specific for localized high bone turnover, reflecting bone resorption of newly formed type I collagen by osteoclasts, has shown a strong correlation to the number of bone metastases determined by scintigraphy in patients with breast and prostate cancers. A similar pattern of local high bone turnover has been observed by scintigraphy in patients with OA, thus ALPHA CTX was investigated as a potential OA marker. Urinary CTXII, a well studied marker which detects the C-telopeptide of type II collagen, has previously been shown to be associated with radiographic disease and OA progression. We hypothesize that urinary biomarkers related to degradation of types I and II collagen, ALPHA CTX and CTXII, may be indicative of OA severity and correlate to amount of high bone turnover determined by bone scan. Methods: A total of 159 participants (118 women, 41 men) were included who met ACR criteria for symptomatic OA and had the presence of Kellgren Lawrence grade 1-4 radiographic OA in at least one knee. In addition to KL grade, which represents global OA severity, compartmental OA severity, based on scoring of osteophytes and joint space narrowing (range of 0-3 for each feature), was determined using the standardized OARSI radiographic atlas. Late phase bone scan images, indicative of bone turnover, were obtained 2 hours after administration of 99m Tc-MDP. Four views of each knee (anterior, posterior, medial, and lateral) were obtained to precisely localize intensity and site of uptake. Bone scan images were scored semiquantitatively by two readers at 16 joint sites, each of which was scored on a scale of 0-3, where 0=normal, 1=mild, 2=moderate, and 3=intense. Urine samples were obtained and stored at -80C until analysis. Concentrations of urinary markers, ALPHA CTX and CTXII (Nordic Biosciences) were determined by ELISA and normalized to creatinine concentration. All data were transformed logarithmically to obtain normality. All aspects of this study were approved by the Institutional Review Board. Results: Urinary ALPHA CTX did not correlate with severity of knee OA based on the static radiographic features (OST and JSN) but did correlate with the dynamic measure of bone turnover based on intensity of bone scintigraphic uptake in the medial knee compartment. Concentrations of urinary CTXII were strongly correlated with knee OA severity based on osteophyte (medial > lateral OST, Table 1 ), but not degree of joint space narrowing. Urinary CTXII also correlated with the dynamic measure of bone turnover showing a correlation with intensity of bone scintigraphic uptake in the knee (medial > lateral compartment but not the patellofemoral compartment, Table 2 ). Discussion: Urinary ALPHA CTX and CTXII are sensitive markers capable of reflecting accelerated bone turnover in patients with knee OA. Both markers correlated with active bone turnover in the knee. In addition, uCTXII correlated with radiographic OST scores. It has been suggested that the main source of uCTXII is remodeling of type II collagen of mineralized tissue including osteophytes and the mineralized interface between cartilage and bone. This supposition is supported by these data as concentrations of uCTXII were highly correlated to the severity of OA as measured by osteophyte formation, particularly of the medial compartment. The significant association of concentrations of collagenous urinary markers, ALPHA CTX and CTXII, to knee bone turnover by bone scintigraphy suggests that these markers may be useful non-invasive surrogates for active bone turnover in knee osteoarthritis. Purpose: Osteoarthritis (OA) is the most common rheumatic pathology, characterized mainly by cartilage degradation. Despite its high prevalence, the diagnosis methods currently available are limited and lacked of sensitivity. Therefore, there is a considerable interest pointed in the characterization of new specific OA biomarkers in biological fluids. In this work we aimed to set up a proteomic method for the large-scale identification and quantisation of proteins in serum from OA patients and their comparison with healthy donors. Methods: Serum samples were obtained from OA patients at different stages of the disease (50 samples from grade II and 50 from grade IV), and 50 control donors. To reduce interindividual variability, samples were grouped in pools made from 10 patients. To reduce the dynamic range of protein concentrations and be able to identify minority proteins, the top twenty most abundant proteins in crude serum fluids were removed by affinity chromatography using the immunodepletion column ProteoPrep ® 20 (Sigma Aldrich). Proteins from each pool were quantified, digested with trypsin and differentially labelled with isobaric tags using iTRAQ methodology (ABSCIEX). Then, peptides from the three conditions were mixed, separated and analyzed by two dimensional LC coupled to MALDI-TOF/TOF mass spectrometry. Identification and relative quantification of the proteins were performed using ProteinPilot 2.0 software (ABSCIEX). Only proteins identified with at least 95% confidence were reported. PSPEP program was used independently to calculate False Discovery Rates.
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Results:
The immunodepletion and subsequent proteomic analysis of the samples led to the identification of around 160 different proteins in the serum pools, with at least one peptide and a confidence higher than 99.9%. Measurement of the different iTRAQ tags intensities allowed the relative quantification of each protein under the three conditions of the study (control, OA grade II and OA grade IV). At this point, we have already analyzed results from 60 samples. Data were normalized and we considered significant those changes with a ratio OA:N >1.2 or <0.8 and a p-value below 0.05. With these considerations, 29 proteins were found to be modified in the serum of OA patients (17 increased and 12 decreased) when compared to Table 1 ). From these, 12 were altered independently of the degree of the disease, 6 were modified only in early stages (grade II), and 11 exclusively in advanced OA (grade IV). The reported altered proteins, which are now putative OA biomarker candidates, are involved in a wide range of biological functions, such as immune response, inflammation processes, lipid metabolism, oxidative stress defence, transport or cell adhesion. Conclusions: A number of novel putative OA serum protein biomarkers have been described. Validation of these results on a higher number of samples will be necessary for the design of a final panel, which will undoubtedly be useful for OA diagnosis and progression studies. Purpose: In kOA disease progression and chronic inflammation is promoted by combinations of principle components of angiogenesis, the kallikrein-kinin and rennin-angiotensin systems, which play essential roles in the maintenance of vascular immune homeostasis.The humoral immune response represents a form of biological amplification of signals that are otherwise weak due to very low concentrations of self-antigen, especially in the early stages of kOA. To investigate the specific presence of NA (IgM, IgG, IgA) to EM (BK, ANII, VEGF, bFGF) in the peripheral blood sera of patients with kOA and healthy individuals: focusing on novel immune disease-associated biomarkers of angiogenesis. Methods: In order to quantify NA to EM in the sera, were designed, synthesized and then used to develop an ELISA, in which antigens coupled to matrix was coated on microtiters plates. Serum samples were incubated in the plates, after which bound Ig anti-EM was detected with mouse anti-human Ig-HRP. Levels NA-EM in a cohort of controls differed by more than 100-fold, whereas the fluctuation of EM-NA levels in individuals over time was small (coefficient of variation 8%). Following this procedure, we examined variations in the levels of NA recognized a panel of self-antigens in the sera from healthy individuals and kOA patients. Blood samples were obtained from a cohort of 250 patients with symptomatic kOA (age range 45-79) fulfilling the American College of Rheumatology criteria for OA of the knee joint and 250 age-and sex-matched healthy individuals. All kOA patients had involvement of the knee joint with typical radiographic changes graded Kellgren&Lawrence classification. Pain was scored on a visual analogue scale (VAS) immediately after walking 50 m. All kOA patients are with persistent pain longer than 6 months. Parameters for function were performed by Lequesne's functional indexes. Results: Different classes of NA (IgM, IgG, IgA) to EM (BK, ANII, VEGF, bFGF) were detected with our ELISA protocol in the sera of kOA patients as well as in the sera of healthy individuals. At time of inclusion kOA patients (100%) had significantly higher serum BK-IgG levels relative to normal
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